{"id":"tp-56261","type":"article-newspaper","title":"SELLAS Shares Rise 20% as It Expects Leukemia Trial Results This Month","author":"Enna Lee","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/investing/56261","datePublished":"2026-11-13T03:47:10.000Z","dateModified":"2026-11-13T03:47:10.000Z","language":"en","abstract":"The company expects results from its Phase 3 REGAL study of galinpepimut-S. Its quarterly loss per share was in line with Wall Street expectations.","section":"Investing","references":[{"title":"our earlier coverage of the trial milestone","url":"https://www.tokenpost.com/news/business/43000"}]}